Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Neoplasms 1Mental Fatigue 1Fatigue 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Sildenafil Citrate × 90 days × Clear all
NCT06123156 2026-05-12

RECTIL

University Hospital, Rouen

Phase 3 Recruiting
188 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06800092 2026-05-11

SPARC

The University of Texas Medical Branch, Galveston

Phase 2/3 Not yet recruiting
30 enrolled

Fatigue, Mental Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡